Abstract
Prostate-specific membrane antigen (PSMA), also known as glutamate carboxypeptidase II, is a potential target protein for the imaging and treatment of patients with prostate cancer because of its o...
Funding Information
  • This paper was supported by the National Research Foundation of Korea (2019R1A6A1A03031807 and 2020R1A2C2005919)

This publication has 61 references indexed in Scilit: